切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (05) : 569 -574. doi: 10.3877/cma.j.issn.1673-5250.2023.05.010

论著

微小RNA-199a-3p调控CD4T细胞表达参与肺炎支原体肺炎患儿免疫反应研究
罗晨, 宗开灿(), 李世颖, 傅应亚   
  1. 重庆市第七人民医院呼吸内科,重庆 400054
    重庆医科大学附属第二医院感染科,重庆 400010
  • 收稿日期:2022-08-10 修回日期:2023-03-28 出版日期:2023-10-01
  • 通信作者: 宗开灿

MicroRNA-199a-3p participates in the immune response after Mycoplasma pneumoniae infection in children by regulating the expression of CD4+ T cells

Chen Luo, Kaican Zong(), Shiying Li, Yingya Fu   

  1. Department of Respiratory Medicine, The Seventh People′s Hospital of Chongqing, Chongqing 400054, China
    Department of Infection, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
  • Received:2022-08-10 Revised:2023-03-28 Published:2023-10-01
  • Corresponding author: Kaican Zong
  • Supported by:
    Scientific Research Project of Chongqing Health Commission(2018ZDXM040)
引用本文:

罗晨, 宗开灿, 李世颖, 傅应亚. 微小RNA-199a-3p调控CD4T细胞表达参与肺炎支原体肺炎患儿免疫反应研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 569-574.

Chen Luo, Kaican Zong, Shiying Li, Yingya Fu. MicroRNA-199a-3p participates in the immune response after Mycoplasma pneumoniae infection in children by regulating the expression of CD4+ T cells[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 569-574.

目的

探讨微小RNA(miR)-199a-3p调控CD4T细胞表达,参与肺炎支原体肺炎(MPP)患儿免疫反应及其发病机制。

方法

选择2018年1月至2020年12月重庆市第七人民医院收治的500例MPP患儿为研究对象,并将其纳入观察组,将同期在该院进行健康体检的200例儿童纳入对照组。将进行体外试验的THP-1细胞培养后,随机分为miR-199a-3p siRNA组(n=3,转染miR-199a-3p siRNA),miRNA mimic组(n=3,转染miRNA mimic)及未处理组(n=3,等量RPMI 1640完全培养基处理),采用外购肺炎支原体(MP)中提取的脂质相关膜蛋白(LAMP),刺激上述3组THP-1细胞后,进行相关试验。采用独立样本t检验,对观察组及对照组受试儿的外周血单核细胞中miR-199a-3p/U6、CD4T细胞比例,以及血清白细胞介素(IL)-6、IL-17、IL-23及粒细胞-巨噬细胞集落刺激因子(GM-CSF)水平进行统计学比较。采用单因素方差分析及LSD-t检验,对3组THP-1细胞中IL-6、IL-17、IL-23及GM-CSF表达水平进行总体及两两比较。采用Pearson相关性分析法,对LAMP刺激后THP-1细胞中CD4T细胞表达水平与miR-199a-3p表达水平的相关性进行分析。本研究经重庆市第七人民医院伦理委员会批准(审批文号:LLH201708-02)。所有受试儿监护人对本研究均知情同意,并签署知情同意书。

结果

①观察组患儿外周血单核细胞中miR-199a-3p/U6为0.55±0.12,低于对照组的0.87±0.09;外周血单核细胞中CD4T细胞比例,以及血清IL-6、IL-17、IL-23及GM-CSF水平分别为(14.4±3.8)%、(0.52±0.08) ng/L、(36.2±5.1) ng/L、(2.89±0.21) ng/mL、(273.8±30.2) mg/L,均分别高于对照组的(6.7±2.0)%、(0.41±0.09) ng/L、(23.9±5.9) ng/L、(1.56±0.14) ng/mL、(163.3±13.8) mg/L,并且上述差异均有统计学意义(t=38.44、34.30、9.29、15.56、44.23、66.24,均为P<0.001)。②LAMP刺激后,miRNA mimic组THP-1细胞中IL-6、IL-17、IL-23及GM-CSF表达水平,均分别高于miR-199a-3p siRNA组及未处理组,并且差异均有统计学意义(P<0.05)。③LAMP刺激后,THP-1细胞中CD4T细胞相对表达水平与miR-199a-3p相对表达水平呈负相关关系(r=—0.643,P=0.003)。

结论

miR-199a-3p可能通过调控CD4T细胞的表达,参与MPP患儿免疫反应。

Objective

To investigate the mechanism by which microRNA(miR)-199a-3p regulates the expression of CD4+ T cells and participates in the immune response of children with Mycoplasma hyopneumoniae pneumonia (MPP).

Methods

From January 2018 to December 2020, a total of 500 children with MPP admitted to the Seventh People′s Hospital of Chongqing were selected as the study subjects and included in observation group. And 200 children who underwent health examinations at the same hospital during the same period were included in control group. After the THP-1 cells for in vitro experimentation were cultured, they were randomly divided into miR-199a-3p siRNA group (n=3, transfected miR-199a-3p siRNA), miRNA mimic group (n=3, transfected miRNA mimic) and untreated group (n=3, treated with equal RPMI 1640 complete medium), and the lipid-associated membrane proteins (LAMP) extracted from purchased Mycoplasma pneumoniae(MP) were used to stimulate the above three groups of THP-1 cells for related experiments. The miR-199a-3p/U6 and proportion of CD4+ T cells in peripheral blood mononuclear cells, and serum interleukin (IL)-6, IL-17, IL-23 and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels between observation group and control group were statistically compared by independent-samples t test. One-way ANOVA and LSD-t test were used to overall and pairwise compare the expression levels of IL-6, IL-17, IL-23 and GM-CSF in three groups of THP-1 cells. Pearson correlation analysis was used to analyze the correlation between CD4+ T cell expression levels and miR-199a-3p expression levels in THP-1 cells after stimulated by LAMP. This study was approved by the Ethics Committee of the Seventh People′s Hospital of Chongqing (Approval No. LLH201708-02). All the guardians of the children gave informed consent to the study and signed the informed consent forms.

Results

① miR-199a-3p/U6 in peripheral blood mononuclear cells of children in observation group was 0.55±0.12, which was lower than that of 0.87±0.09 in control group; The proportion of CD4+ T cells in peripheral blood mononuclear cells, and the serum levels of IL-6, IL-17, IL-23 and GM-CSF were (14.4±3.8)%, (0.52±0.08) ng/L, (36.2±5.1) ng/L, (2.89±0.21) ng/mL and (273.8±30.2) mg/L, respectively, which were higher than those of (6.7±2.0)%, (0.41±0.09) ng/L, (23.9±5.9) ng/L, (1.56±0.14) ng/mL and (163.3±13.8) mg/L, respectively in control group, and the above differences were statistically significant (t=38.44, 34.30, 9.29, 15.56, 44.23, 66.24; all with P<0.001). ② After LAMP stimulation, the expression levels of IL-6, IL-17, IL-23 and GM-CSF in THP-1 cells in miRNA mimic group were higher than those in miR-199a-3p siRNA group and untreated group, respectively, and the differences were statistically significant (P<0.05). ③The expression level of CD4+ T cells in THP-1 cells after LAMP stimulation was negatively correlated with the expression level of miR-199a-3p (r=—0.643, P=0.003).

Conclusion

miR-199a-3p may be involved in the immune response of children with MPP by regulating the expression of CD4+ T cells.

表1 观察组与对照组受试儿外周血各项检测指标比较(±s)
表2 LAMP刺激后,3组THP-1细胞中各项指标表达水平总体比较及两两比较(μg/L,±s)
[1]
Xu YC, Li SX, Liu JL, et al. Impact of Epstein-Barr virus coinfection in Mycoplasma pneumoniae pneumonia[J]. Medicine, 2020, 99(16): e19792. DOI: 10.1097/MD.0000000000019792.
[2]
Liu JR, Zhao F, Lu J, et al. High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia[J]. BMC Infectious Diseases, 2019, 19(1): 1045. DOI: 10.1186/s12879-019-4667-y.
[3]
Matthys I, Borsboom D, Steyaert S, et al. A plethora of manifestations following a Mycoplasma pneumoniae infection: a case report[J]. Acta Clinica Belgica, 2020, 75(3): 229-234. DOI: 10.1080/17843286.2019.1578029.
[4]
朱贲贲,白在先,杨鹏杰. miRNA对心肌细胞肥大的调控作用及在心肌肥厚发病中的分子生物学作用机制研究进展[J]. 山东医药2020, 60(24): 112-115. DOI: 10.3969/j.issn.1002-266X.2020.24.030.
[5]
Shi S, Zhang XQ, Zhou Y, et al. Immunosuppression reduces lung injury caused by Mycoplasma pneumoniae infection[J]. Sci Rep, 2019, 9(1): 7147. DOI: 10.1038/s41598-019-43451-9.
[6]
Huang RY, Li JB, Pan F, et al. The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis[J]. Am J Transl Res, 2020, 12(1): 32-44.
[7]
农东芳. 小儿肺炎支原体感染行快速血清学检验与微生物培养检测的价值比较[J/OL]. 临床检验杂志(电子版), 2020, 9(2): 68-69.
[8]
Wen P, Wei M, Guo X, et al. Mycoplasma pneumoniae infection mimicking tuberculous pleurisy in a young woman: a case report and literature review[J]. J Int Med Res, 2020, 48(4): 300060520918701. DOI: 10.1177/0300060520918701.
[9]
王如刚. 浅析哮喘患儿肺炎衣原体及肺炎支原体感染的临床特征[J]. 临床医药文献电子杂志2019, 6(20): 61-62. DOI: 10.16281/j.cnki.jocml.2019.20.040.
[10]
Mǎrginean CO, Georgescu AM, Meliţ LE. Arthritis associated with Mycoplasma pneumoniae in a pediatric patient: a case report[J]. Medicine (Baltimore), 2021, 100(2): e24316. DOI: 10.1097/MD.0000000000024316.
[11]
Su M, Wang Q, Li D, et al. Prevalence and clinical characteristics of hospitalized children with community-acquired Mycoplasma pneumoniae pneumonia during 2017/2018, Chengde, China[J]. Medicine (Baltimore), 2021, 100(5): e23786. DOI: 10.1097/MD.0000000000023786.
[12]
Kumar S, Kumar S, Chakravarti A, et al. Detection of respiratory syncytial virus & Mycoplasma pneumoniae in paediatric lower respiratory tract infections[J]. Indian J Med Res, 2019, 150(3): 306. DOI: 10.4103/ijmr.IJMR_983_18.
[13]
魏飞宇,范洁,高田,等. miR-199-3p通过靶向调控SP1促进成纤维细胞增殖对心房颤动心房重构的影响[J]. 临床心血管病杂志2020, 36(6): 523-530. DOI: 10.13201/j.issn.1001-1439.2020.06.007.
[14]
Ranjbar R, Halaji M. Epidemiology of Mycoplasma pneumoniae prevalence in Iranian patients: a systematic review and Meta-analysis[J]. J Med Microbiol, 2019, 68(11): 1614-1621. DOI: 10.1099/jmm.0.001079.
[15]
Yan C, Yang HJ, Sun HM, et al. Diversity in genotype distribution of Mycoplasma pneumoniae obtained from children and adults[J]. Jpn J Infect Dis, 2020, 73(1): 14-18. DOI: 10.7883/yoken.JJID.2019.037.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 戴睿, 张亮, 陈浏阳, 张永博, 吴丕根, 孙华, 杨盛, 孟博. 肠道菌群与椎间盘退行性变相关性的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 546-549.
[3] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[8] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[9] 张龙, 孙善柯, 徐伟, 李文柱, 李俊达, 池涌泉, 何广胜, 成峰, 王学浩, 饶建华. 腹腔镜脾切除治疗血液系统疾病的临床疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 870-875.
[10] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[11] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[12] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[13] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[14] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?